<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03662386</url>
  </required_header>
  <id_info>
    <org_study_id>EBA_2017_21</org_study_id>
    <nct_id>NCT03662386</nct_id>
  </id_info>
  <brief_title>Prospective Analysis of &quot;Genotype-phenotype&quot; Correlations Observed in a Large Cohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD</brief_title>
  <acronym>GEPHIRD</acronym>
  <official_title>Prospective Analysis of &quot;Genotype-phenotype&quot; Correlations Observed in a Large Cohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will carry out a detailed descriptive analysis of a large population of patients
      with hereditary retinal dystrophies (HRD): clinical, paraclinical and genetic data.

      The information drawn from these analyzes will provide a better understanding of the
      pathophysiology of these rare diseases and this may ultimately impact the medical management
      of patients (targeted therapy).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2018</start_date>
  <completion_date type="Anticipated">September 2032</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the phenotypic characteristics of patients with hereditary retinal dystrophies.</measure>
    <time_frame>Baseline</time_frame>
    <description>Phenotypic diagnosis of the type of retinal dystrophy based on all the examinations performed as part of the usual care and examinations added by the research (OCT-Angiography - Optical coherence tomography, and visual acuity with ETDRS scale : Early Treatment Diabetic Retinal Study, ETDRS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of the genotypic characteristics of patients with hereditary retinal dystrophies.</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of the genetic mutations responsible for retinal dystrophy in order to confirm the phenotypic diagnosis and identify correlation between the phenotypic and genotypic characteristics</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hereditary Retinal Dystrophies</condition>
  <arm_group>
    <arm_group_label>Patients with suspicion of hereditary retinal dystrophy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT-A</intervention_name>
    <description>Optical coherence tomography angiography (OCT-A)</description>
    <arm_group_label>Patients with suspicion of hereditary retinal dystrophy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Visual acuity (ETDRS)</intervention_name>
    <description>Visual acuity tested with ETDRS score (Early Treatment Diabetic Retinopathy Study)</description>
    <arm_group_label>Patients with suspicion of hereditary retinal dystrophy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized for suspicion of hereditary retinal distrophy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients hospitalized for suspicion of hereditary retinal dystrophy

          -  Benefiting as part of the care of a genetic analysis

        Exclusion Criteria:

        - Patient under a measure of legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Elise BOULANGER SCEMAMA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ophtalmologique A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON</last_name>
    <phone>148036431</phone>
    <phone_ext>+33</phone_ext>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise BOULANGER SCEMAMA</last_name>
      <email>eboulanger@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>August 1, 2018</study_first_submitted>
  <study_first_submitted_qc>September 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2018</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hereditary retinal dystrophies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Dystrophies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

